BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21899776)

  • 1. Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.
    Manzoor S; Idrees M; Ashraf J; Mehmood A; Butt S; Fatima K; Akbar H; Rehaman IU; Qadri I
    Virol J; 2011 Sep; 8():431. PubMed ID: 21899776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
    Khalid M; Manzoor S; Ahmad H; Asif A; Bangash TA; Latif A; Jaleel S
    Mol Biol Rep; 2018 Dec; 45(6):2625-2630. PubMed ID: 30343397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
    Hino K; Nishina S; Sasaki K; Hara Y
    Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis.
    Manzoor S; Khalid M; Idrees M
    PLoS One; 2022; 17(5):e0259727. PubMed ID: 35594248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
    Huang XX; McCaughan GW; Shackel NA; Gorrell MD
    Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
    Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
    World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.
    Masalova OV; Lesnova EI; Solyev PN; Zakirova NF; Prassolov VS; Kochetkov SN; Ivanov AV; Kushch AA
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.
    Shrivastava S; Mukherjee A; Ray R; Ray RB
    J Virol; 2013 Nov; 87(22):12284-90. PubMed ID: 24006444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.
    Alisi A; Arciello M; Petrini S; Conti B; Missale G; Balsano C
    PLoS One; 2012; 7(8):e44147. PubMed ID: 22937161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes.
    Benegiamo G; Vinciguerra M; Mazzoccoli G; Piepoli A; Andriulli A; Pazienza V
    Dig Dis Sci; 2012 Jun; 57(6):1598-603. PubMed ID: 22526584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
    PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 8 is increased in hepatitis C virus cells and its ectopic expression induces apoptosis of SMMC7721 cells.
    Sun MZ; Dang SS; Wang WJ; Jia XL; Zhai S; Zhang X; Li M; Li YP; Xun M
    World J Gastroenterol; 2013 Oct; 19(37):6178-87. PubMed ID: 24115814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.
    Elsemman IE; Mardinoglu A; Shoaie S; Soliman TH; Nielsen J
    Mol Biosyst; 2016 Apr; 12(5):1496-506. PubMed ID: 27040643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
    Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
    Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
    Maryam M; Idrees M
    J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
    Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
    Front Immunol; 2021; 12():692263. PubMed ID: 34497603
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
    Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
    J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.